Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013

News provided by

Jun 26, 2013, 12:26 ET

NEW YORK, June 26, 2013 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0886931/Deep-Vein-Thrombosis-DVT-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Summary

GlobalData's clinical trial report, "Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013" provides data on the Deep Vein Thrombosis (DVT) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Deep Vein Thrombosis (DVT). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Deep Vein Thrombosis (DVT). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of CContents 2
List of Tables 5
List of Figures 7
Introduction 8
Deep Vein Thrombosis (DVT) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Deep Vein Thrombosis (DVT) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Bristol-Myers Squibb Company 37
Clinical Trial Overview of Bristol-Myers Squibb Company 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Daiichi Sankyo, Inc. 39
Clinical Trial Overview of Daiichi Sankyo, Inc. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Daiichi Sankyo Company, Limited 42
Clinical Trial Overview of Daiichi Sankyo Company, Limited 42
Boehringer Ingelheim GmbH 43
Clinical Trial Overview of Boehringer Ingelheim GmbH 43
LEO Pharma A/S 44
Clinical Trial Overview of LEO Pharma A/S 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Daiichi Sankyo Europe GmbH 46
Clinical Trial Overview of Daiichi Sankyo Europe GmbH 46
Diakron Pharmaceuticals, Inc. 47
Clinical Trial Overview of Diakron Pharmaceuticals, Inc. 47
ThromboGenics NV 48
Clinical Trial Overview of ThromboGenics NV 48
Green Cross Corporation 49
Clinical Trial Overview of Green Cross Corporation 49
Bayside Health 50
Clinical Trial Overview of Bayside Health 50
Portola Pharmaceuticals, Inc. 51
Clinical Trial Overview of Portola Pharmaceuticals, Inc. 51
Diagnostica Stago SAS 52
Clinical Trial Overview of Diagnostica Stago SAS 52
AGEN Biomedical Limited 53
Clinical Trial Overview of AGEN Biomedical Limited 53
Generex Biotechnology Corporation 54
Clinical Trial Overview of Generex Biotechnology Corporation 54
Clinical Trial Overview of Top Institutes / Government 55
Brigham and Women's Hospital 55
Clinical Trial Overview of Brigham and Women's Hospital 55
Hamilton Health Sciences 56
Clinical Trial Overview of Hamilton Health Sciences 56
Ottawa Hospital Research Institute 57
Clinical Trial Overview of Ottawa Hospital Research Institute 57
McMaster University 58
Clinical Trial Overview of McMaster University 58
Academic Medical Centre 59
Clinical Trial Overview of Academic Medical Centre 59
Intermountain Healthcare, Inc. 60
Clinical Trial Overview of Intermountain Healthcare, Inc. 60
Jewish General Hospital 61
Clinical Trial Overview of Jewish General Hospital 61
St. Orsola Hospital 62
Clinical Trial Overview of St. Orsola Hospital 62
Azienda Ospedaliera Universitaria Policlinico catania 63
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 63
Assistance Publique - Hopitaux de Paris 64
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 64
University Hospital, Grenoble 65
Clinical Trial Overview of University Hospital, Grenoble 65
Washington University School of Medicine 66
Clinical Trial Overview of Washington University School of Medicine 66
University of Pennsylvania 67
Clinical Trial Overview of University of Pennsylvania 67
University of Oklahoma 68
Clinical Trial Overview of University of Oklahoma 68
University Hospital Basel 69
Clinical Trial Overview of University Hospital Basel 69
Leiden University Medical Center 70
Clinical Trial Overview of Leiden University Medical Center 70
National Taiwan University Hospital 71
Clinical Trial Overview of National Taiwan University Hospital 71
Centre Hospitalier Universitaire de Saint Etienne 72
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 72
Rambam Health Care Campus 73
Clinical Trial Overview of Rambam Health Care Campus 73
The University of Chicago 74
Clinical Trial Overview of The University of Chicago 74
Five Key Clinical Profiles 75
Appendix 180
Abbreviations 180
Definitions 180
Research Methodology 181
Secondary Research 181
About GlobalData 182
Contact Us 182
Disclaimer 182
Source 183

List of Tables

Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 15
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Deep Vein Thrombosis (DVT) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, E7 Countries, 2013* 20
Deep Vein Thrombosis (DVT) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 34
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 37
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 38
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2013* 39
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 40
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 41
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 42
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2013* 43
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2013* 44
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 45
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Europe GmbH, 2013* 46
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Diakron Pharmaceuticals, Inc., 2013* 47
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2013* 48
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2013* 49
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2013* 50
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Portola Pharmaceuticals, Inc., 2013* 51
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Diagnostica Stago SAS, 2013* 52
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by AGEN Biomedical Limited, 2013* 53
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2013* 54
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 55
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2013* 56
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013* 57
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 58
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 59
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Intermountain Healthcare, Inc., 2013* 60
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Jewish General Hospital, 2013* 61
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2013* 62
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2013* 63
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 64
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2013* 65
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 66
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 67
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2013* 68
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2013* 69
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 70
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 71
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2013* 72
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2013* 73
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 74

List of Figures

Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 15
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Deep Vein Thrombosis (DVT) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Deep Vein Thrombosis (DVT) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 181